Medical Weight Loss for West Allis, Wisconsin Residents

West Allis, Wisconsin residents get physician-supervised weight loss by telehealth from New Hope Weight Loss: a $119 doctor review, then compounded semaglutide from $166/month or tirzepatide from $233/month.

Physician-supervised GLP-1 programs from $166/month, serving West Allis through telehealth from our Costa Mesa, California clinic. Doctor review $119. Over 5,400 patients treated.

Private and discreet across Wisconsin: there is no local West Allis office to walk into and no one to run into, your entire program runs through secure video and direct shipping. Doctor review just $119 (medication separate).

Why West Allis Residents Choose New Hope Weight Loss

If past attempts left you frustrated, West Allis, the difference here is structure and honesty. There is a real physician, Dr. Anjmun Sharma, behind your plan, a transparent price you can see up front, and a program that meets you by telehealth instead of dragging you across Wisconsin for every visit. Compounded semaglutide and tirzepatide are not magic and they are not FDA-approved, but paired with steady medical guidance they give a lot of people a genuine path forward.

West Allis is served by telemedicine from our Costa Mesa, California clinic. The same physician-supervised semaglutide and tirzepatide programs are available by secure video, with medication shipped to your door.

Your zip code in West Allis, Wisconsin does not change the medicine or the doctor, only the way you connect, since Dr. Anjmun Sharma supervises every patient remotely from Costa Mesa. We care for patients throughout West Allis and the southwestern Milwaukee metro area. A licensed care coordinator stays reachable by message and phone, so help is a few taps away anywhere in Wisconsin.

There is no separate "out of town" rate, so West Allis and Wisconsin patients get the same program at the same price as everyone Dr. Sharma sees. If you would rather spread payments out, West Allis patients can use Klarna or Affirm at checkout instead of paying the full cost at once. Wherever you live in Wisconsin, New Hope Weight Loss provides physician-supervised GLP-1 care by secure telehealth from our Costa Mesa, California clinic, with no need to travel for a visit.

GLP-1 Weight Loss Programs Available

Semaglutide: the 90-Day Metabolic Reset

If you live in West Allis and want a clear starting point, this is it. Semaglutide, the active ingredient also used in Wegovy and Ozempic, costs from $166 per month or $499 for the 90-day program. Branded-drug trials showed roughly 15 to 17 percent average weight loss. Compounded semaglutide is not FDA-approved and not brand-identical, so results vary.

Tirzepatide: the dual GLP-1 and GIP option

For patients who want a second lever, tirzepatide starts at $233 per month and acts on both GLP-1 and GIP receptors. Up to 22.5 percent body-weight loss appeared in branded-drug trials at qualifying doses, which is not typical. It shares an active ingredient with Mounjaro and Zepbound.

A $119 physician review is required up front. Medication billed separately. HSA, FSA, Klarna, and Affirm are accepted.

How Telehealth Works for West Allis

No waiting rooms, no commute across West Allis traffic. Everything happens online. You answer a focused intake quiz about your goals and medical background, Dr. Anjmun Sharma reviews it and sees you by secure video (usually within 48 hours), and if a compounded GLP-1 is appropriate she sends the prescription to a state-licensed 503(a) pharmacy. That pharmacy ships your semaglutide or tirzepatide to your West Allis home in cold-pack packaging that keeps it cool the whole way. Follow-up visits are by video as well, so dose adjustments and questions are handled from wherever you are in .

Frequently Asked Questions, West Allis

Does New Hope Weight Loss actually serve West Allis, or only Costa Mesa?

We serve both. Our single physical location sits in Costa Mesa, California, and we extend care to West Allis, Wisconsin through telehealth. Residents across neighborhoods like West Allis and the southwestern Milwaukee metro area qualify the same way. Dr. Anjmun Sharma evaluates whether a compounded GLP-1 plan fits you during your initial video appointment.

Can the whole process be done remotely from West Allis?

Yes, it is fully remote. There is no in-person requirement for West Allis patients at any stage. You meet Dr. Sharma over video, complete intake online, and receive ongoing support by message. Approved prescriptions arrive at your door in insulated cold-pack shipping that protects the medication during delivery.

How much will a West Allis patient pay?

Plan on $119 for the physician visit. Semaglutide runs from $166 monthly, with a $499 option for 90 days, and tirzepatide from $233 monthly. The medication cost is separate from the visit. HSA, FSA, Klarna, and Affirm are all welcome, and West Allis residents pay no added distance fee.

What areas of West Allis do you serve?

We serve patients from across West Allis by telehealth, including West Allis and the southwestern Milwaukee metro area.

How soon can a West Allis patient start treatment?

Most West Allis patients complete the online intake in minutes and have Dr. Sharma's video review within about 48 hours. If you are a candidate and telehealth-eligible, medication ships shortly after, so many patients begin within roughly a week of starting.

West Allis Residents, Get Started Today

Doctor review $119. Semaglutide from $166/mo. Tirzepatide from $233/mo. Medication separate.

Start My Journey →

New Hope Weight Loss | clinic at 1503 South Coast Drive, Suite 322, Costa Mesa, CA 92626 | (657) 837-3342 | Serving West Allis, Wisconsin by telehealth. Telehealth availability and eligibility are confirmed during the medical consultation.

Wegovy® and Ozempic® are registered trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company. New Hope Weight Loss is not affiliated with or endorsed by these companies. Compounded semaglutide and tirzepatide are prepared by licensed U.S. pharmacies and are not FDA-approved, not brand-identical, and not reviewed by the FDA for safety, effectiveness, or quality.